{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:16:38Z","timestamp":1777551398351,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004410","name":"T\u00fcrkiye Bilimsel ve Teknolojik Ara\u015ftirma Kurumu","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004410","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.ejps.2020.105644","type":"journal-article","created":{"date-parts":[[2020,11,13]],"date-time":"2020-11-13T11:59:34Z","timestamp":1605268774000},"page":"105644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Evaluation of the hypoglycemic effect of exendin-4\u2019s new oral self-nanoemulsifying system in rats"],"prefix":"10.1016","volume":"158","author":[{"given":"Merve","family":"Celik-Tekeli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nevin","family":"Celebi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9382-9605","authenticated-orcid":false,"given":"M. Yasin","family":"Tekeli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yesim","family":"Aktas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2020.105644_bib0001","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.addr.2016.02.004","article-title":"Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials","volume":"106","author":"Aguirre","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105644_bib0002","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1080\/02652048.2019.1692945","article-title":"Development and characterization of exendin-4 loaded self-nanoemulsifying system and in vitro evaluation on Caco-2 cell line","volume":"37","author":"Aktas","year":"2020","journal-title":"J. Microencapsul."},{"key":"10.1016\/j.ejps.2020.105644_bib0003","first-page":"539","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus","volume":"15","author":"Alberti","year":"1998","journal-title":"Provisional report of a WHO consultation. Diabet. Med"},{"key":"10.1016\/j.ejps.2020.105644_bib0004","first-page":"963","article-title":"Long-acting preparations of exenatide","volume":"7","author":"Cai","year":"2013","journal-title":"Drug Des. Devel. Ther."},{"key":"10.1016\/j.ejps.2020.105644_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4103\/0250-474X.62228","article-title":"Exenatide: A new promising antidiabetic agent","volume":"72","author":"Chakraborti","year":"2010","journal-title":"Indian J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2020.105644_bib0006","series-title":"Nanostructures for Cancer Therapy","first-page":"653","article-title":"Self-emulsifying delivery systems: One step ahead in improving solubility of poorly soluble drugs","author":"Chavda","year":"2017"},{"key":"10.1016\/j.ejps.2020.105644_bib0007","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1517\/17425247.2015.999038","article-title":"Self-nano-emulsifying drug delivery systems: An update of the biopharmaceutical aspects","volume":"12","author":"Cherniakov","year":"2015","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ejps.2020.105644_bib0008","doi-asserted-by":"crossref","first-page":"e105","DOI":"10.1016\/j.ddtec.2012.04.005","article-title":"Insight of current technologies for oral delivery of proteins and peptides","volume":"9","author":"Chin","year":"2012","journal-title":"Drug Discov. Today Technol."},{"key":"10.1016\/j.ejps.2020.105644_bib0009","doi-asserted-by":"crossref","first-page":"935","DOI":"10.2165\/00003495-200767060-00008","article-title":"Exenatide: A review of its use in patients with type 2 diabetes mellitus (as an adjunct to metformin and\/or a sulfonylurea)","volume":"67","author":"Cvetkovi\u0107","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.ejps.2020.105644_bib0010","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1007\/s40262-013-0079-0","article-title":"Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides","volume":"52","author":"Diao","year":"2013","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejps.2020.105644_bib0011","first-page":"1","year":"2006","journal-title":"Byetta: EPAR-Scientific Discussion"},{"key":"10.1016\/j.ejps.2020.105644_bib0012","unstructured":"FDA, 2018: BYDUREON\u00ae (exenatide extended-release) for injectable suspension, 1-49. (https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2018\/022200s026lbl.pdf) (accessed 02 September 2020)."},{"key":"10.1016\/j.ejps.2020.105644_bib0013","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1211\/jpp.58.7.0006","article-title":"A comparison of intestinal lymphatic transport and systemic bioavailability of saquinavir from three lipid-based formulations in the anaesthetised rat model","volume":"58","author":"Griffin","year":"2006","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ejps.2020.105644_bib0014","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.biopha.2004.02.001","article-title":"Self-emulsifying drug delivery systems ( SEDDS ) for improved oral delivery of lipophilic drugs","volume":"58","author":"Gursoy","year":"2004","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.ejps.2020.105644_bib0015","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ijpharm.2014.05.047","article-title":"In vivo evaluation of an oral self-microemulsifying drug delivery system (SMEDDS) for leuprorelin","volume":"472","author":"Hintzen","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105644_bib0016","series-title":"International Conference on Harmonization. (CPMP\/ICH\/2736\/99)","article-title":"ICH Guideline Q1A(R2) Stability Testing of New Drug Substances and Products","year":"2003"},{"key":"10.1016\/j.ejps.2020.105644_bib0017","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/j.drudis.2013.05.011","article-title":"Future directions for peptide therapeutics development","volume":"18","author":"Kaspar","year":"2013","journal-title":"Drug Discov. Today."},{"key":"10.1016\/j.ejps.2020.105644_bib0018","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.apsb.2014.09.001","article-title":"Pharmacokinetic aspects and in vitro\u2013in vivo correlation potential for lipid-based formulations","volume":"4","author":"Kollipara","year":"2014","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejps.2020.105644_bib0019","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.addr.2016.02.011","article-title":"Oral delivery of diabetes peptides \u2014 Comparing standard formulations incorporating functional excipients and nanotechnologies in the translational context","volume":"106","author":"Lakkireddy","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105644_bib0020","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1517\/17425247.2015.1068287","article-title":"Self-emulsifying drug delivery systems in oral (poly) peptide drug delivery","volume":"12","author":"Leonaviciute","year":"2015","journal-title":"Expert Opin Drug Deliv"},{"key":"10.1016\/j.ejps.2020.105644_bib0021","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.ijpharm.2014.10.039","article-title":"Self-nanoemulsifying drug delivery systems for oral insulin delivery: In vitro and in vivo evaluations of enteric coating and drug loading","volume":"477","author":"Li","year":"2014","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105644_bib0022","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/aps.2012.33","article-title":"Pharmacokinetic \/ pharmacodynamic studies on exenatide in diabetic rats","volume":"33","author":"Li","year":"2012","journal-title":"Acta Pharm. Sin."},{"key":"10.1016\/j.ejps.2020.105644_bib0023","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.addr.2018.07.001","article-title":"SEDDS: A game changing approach for the oral administration of hydrophilic macromolecular drugs","volume":"142","author":"Mahmood","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105644_bib0024","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.addr.2018.10.014","article-title":"Successful development of oral SEDDS: screening of excipients from the industrial point of view","volume":"142","author":"Nardin","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105644_bib0025","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.regpep.2003.10.028","article-title":"Pharmacology of exenatide (synthetic exendin-4): A potential therapeutic for improved glycemic control of type 2 diabetes","volume":"117","author":"Nielsen","year":"2004","journal-title":"Regul. Pept."},{"key":"10.1016\/j.ejps.2020.105644_bib0026","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.reactfunctpolym.2010.10.002","article-title":"Oral protein delivery: Current status and future prospect","volume":"71","author":"Park","year":"2011","journal-title":"React. Funct. Polym."},{"key":"10.1016\/j.ejps.2020.105644_bib0027","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.addr.2007.10.014","article-title":"Enhancing intestinal drug solubilisation using lipid-based delivery systems","volume":"60","author":"Porter","year":"2008","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejps.2020.105644_bib0028","first-page":"16","article-title":"Self-nanoemulsifying drug delivery system (SNEDDS) for oral delivery of protein drugs","volume":"362","author":"Rao","year":"2008","journal-title":"III. In vivo oral absorption study. Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105644_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijpharm.2013.02.030","article-title":"Approaches for enhancing oral bioavailability of peptides and proteins","volume":"447","author":"Renukuntla","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ejps.2020.105644_bib0030","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ijbiomac.2013.08.002","article-title":"Combining two technologies: Multifunctional polymers and self-nanoemulsifying drug delivery system (SNEDDS) for oral insulin administration","volume":"61","author":"Sakloetsakun","year":"2013","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ejps.2020.105644_bib0031","first-page":"42","article-title":"Self-Emulsifying Drug Delivery System\u202f: A Strategy to Improve Oral Bioavailability","volume":"11","author":"Sarpal","year":"2014","journal-title":"CRIPS"},{"key":"10.1016\/j.ejps.2020.105644_bib0032","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jconrel.2017.03.008","article-title":"Nanoemulsion: Concepts, development and applications in drug delivery","volume":"252","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ejps.2020.105644_bib0033","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1248\/bpb.b15-00442","article-title":"An investigation into the gastrointestinal stability of exenatide in the presence of pure enzymes, everted intestinal rings and intestinal homogenates","volume":"39","author":"Sun","year":"2016","journal-title":"Biological & pharmaceutical bulletin"},{"key":"10.1016\/j.ejps.2020.105644_bib0034","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.peptides.2009.10.002","article-title":"Recent developments in liposomes, microparticles and nanoparticles for protein and peptide drug delivery","volume":"31","author":"Tan","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/j.ejps.2020.105644_bib0035","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ijpharm.2016.07.061","article-title":"Microemulsions containing long-chain oil ethyl oleate improve the oral bioavailability of piroxicam by increasing drug solubility and lymphatic transportation simultaneously","volume":"511","author":"Xing","year":"2016","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.ejps.2020.105644_bib0036","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.lfs.2005.12.032","article-title":"Effect of chronic psychological stress on insulin release from rat isolated pancreatic islets","volume":"79","author":"Zardooz","year":"2006","journal-title":"Life Sci."},{"key":"10.1016\/j.ejps.2020.105644_bib0037","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1166\/jbn.2012.1371","article-title":"The in vitro and in vivo study on Self-Nanoemulsifying Drug Delivery System (SNEDDS) based on insulin-phospholipid complex","volume":"8","author":"Zhang","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ejps.2020.105644_bib0038","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ejpb.2016.09.013","article-title":"Development, in vitro and in vivo evaluation of a self-emulsifying drug delivery system (SEDDS) for oral enoxaparin administration","volume":"109","author":"Zupan\u010di\u010d","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720304322?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098720304322?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:58:16Z","timestamp":1760529496000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098720304322"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":38,"alternative-id":["S0928098720304322"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105644","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of the hypoglycemic effect of exendin-4\u2019s new oral self-nanoemulsifying system in rats","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2020.105644","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105644"}}